Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Org chart
William H. Collier
President & CEO
William H. Collier
Collapse
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Gaston Picchio
Chief Development Officer
Michael J. Sofia Phd
Chief Scientific Officer
Teams
View all
